We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PHC Plant Health Care Plc

-0.175 (-2.95%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.175 -2.95% 5.75 5.70 5.80 6.10 5.75 6.10 486,763 16:29:55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pesticides, Agric Chems, Nec 11.77M -9.48M -0.0278 -2.07 19.64M
Plant Health Care Plc is listed in the Pesticides, Agric Chems sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 5.93p. Over the last year, Plant Health Care shares have traded in a share price range of 3.20p to 10.20p.

Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £19.64 million. Plant Health Care has a price to earnings ratio (PE ratio) of -2.07.

Plant Health Care Share Discussion Threads

Showing 1376 to 1400 of 1400 messages
Chat Pages: 56  55  54  53  52  51  50  49  48  47  46  45  Older
Everything primed for a serious rerating it seems.
Interesting posts , I dithered and delayed and finally bought a small holding at 5p, I'd been thinking of pulling the trigger at 3pish but didn't ....

The new research out this morning is quite bullish and suggests that if the market doesn't re rate this then a bidder could come along.

It has been a long road to success but they seem to be within touching distance of being profitable . This feels like a significant moment.

They say

We highlight that approaching profitability is a major milestone as that not only significantly lowers the company’s cost of capital, but it also makes the company a much more attractive acquisition target. With such a profitable and proven biological agribiotech solution, we see Plant Health Care as a high-tech AIM-listed company that is at risk of being taken out before investors can enjoy the returns that are now visible after decades of development and investment.

We see Plant Health Care as an undervalued acquisition target that is trading at a discount to the $30m it has invested in PREtec over a decade. Harpin is now delivering a CAGR of around 20% and the PREtec platform is delivering a pipeline of products with excellent on-ground performance, multi-million dollar high-margin revenues – and this is even before its most exciting product, the biological nematicide PHC949, is launched in Brazil this year. With Plant Health Care forecast to trade profitably within a year from now, we see the company as undervalued and at risk of being acquired by a much larger agritech company. We note that the risk of acquisition increases significantly as a tech company nears or reaches profitability, as this derisks the decision making for the acquirer. For a perspective on valuation, Plant Health Care’s closest listed comparable, Biotalys, is pre-revenue with a €20m cost base and a €96m market cap.

Thanks for your balanced comments Cerrito. There are always risks with small companies and PHC are no different; as you know.
I agree, 25% is not a bad growth rate in normal times… however, with the destocking issue, growth went into reverse last year. So sub 25% growth this year building from a -5% baseline would not be so good, especially with so many new markets and products coming on stream for the company. It would suggest a very lukewarm reception for PHC products.

I look at LinkedIn a lot (we all do) and the PHC field teams have worked tirelessly to promote the new product launches. There have been field trials, adverts, promotions as well as conference presentations. Early indications in 2024 are very positive.
The company have growth milestones which they appear to take very seriously. That’s good, and in recent weeks I’ve started to rediscover my optimism. The shareprice recovery also suggests we’re striding forwards.
All IMO.

No surprise that so much attention being placed on the Going Concern Statement which gives me considerable food for thought.
Great that the base case revenue forecast is for increases of 39pc this year and 55pc for H125. I respect the Board and do not see them as having flights of fancy which explains why in terms of money invested, this is my largest holding. I obviously gain comfort from the experience of YTD with the 72pc increase in sales in the first 4 months of this year.
That said the ramifications of reasonable and plausible scenario of growth sub 25pc are not pleasant. 25pc is a v good growth rate.Yes they do have diversification both by crop and geography. What spooks me is that rightly or wrongly I have got it into my head that it is difficult to predict demand in the crop protection/enhancement market given the economics ,price fluctuations and climate issues, as of course recognized by the Chairman in his statement.Indeed I remember about 8 years ago, Croda saying that of all their divisions, the crop one was the most difficult to predict. The 2023 decrease in third party sales in Mexico due to weather and lower commodity prices illustrate the point.
Despite the Friday RNS,I could not find the AR on the website and look forward to going through it carefully.
I hope there is an IMC and I can make the AGM. We need to get a better handle on the working capital ramifications of a revenue increase of 39pc pa, especially given the swings in the cash position in January this year.
Appreciate any comments if you think I am making a mountain out of a molehill on the risks.

The outlook was of most interest to me and it looks as if this year has seen sales reignited.The destocking issues are in the rear view mirror and it's time for the payback on their $30 million of investment made over the past decade.I think the management have the cash situation covered, backed up with the tremendous opportunity that lies ahead.
The Directors have prepared a base case cash forecast that shows we will be able to operate within our existing facilities (including the financing secured after the year-end) for the foreseeable future of at least a year from the date of the approval of these financial statements. The Directors have modeled a variety of possible cash flow forecasts for the twelve months from the date of the approval of the financial statements.
The Group's revenue projections are based on detailed budgets built up by customer from each of the Group's operating segments, and specifically includes growth assumptions in the U.S. to reverse the decline experienced in 2023. The Group's base case shows a revenue increase of 39% in 2024 and 55% in the first half of 2025, which is an increase from the overall decline in 2023 of 5% (which was caused by the distributors managing their inventory levels in the U.S. market). The base case growth rates projected for 2024 and 2025 are comparable to the 40% and 28% overall growth rates achieved in 2022 and 2021 respectively, and the growth rates achieved in 2023 in the South America and EMEAA regions during 2023 of 29% and 41%.

Experience has shown in the first four months of 2024 that projected revenue has started to occur and growth on 2023 has been achieved at a rate which has exceeded the Directors budget....the Directors consider that the Group and Company will trade in a positive scenario.

all i looked at was the outlook and in it ebitda positive and cash flow positive and profit break
Full year results out .RNS 5.05.
Nothing like legislation to boost sales.That and an unforgiving global climate.
Final reporting date is actually the 28th June I believe. I get the feeling that the market for sustainable agrotech is getting rosier benefitting PHC. For example the EU are close to banning ‘forever’; chemicals including pesticides.
Farmers have to replace them with something - nudge - residue free peptides from PHC perhaps?
As things improve I guess PHC will want to lace their 2023 FY reporting with positive forward statements. To be honest the 2023 FY lacks relevance today, given the temporary destocking blip is resolving.

I suppose the pullback Thursday/Friday to be expected after the rapid run up and pte a 3 day weekend both in the UK and US.
Trading activity in line with that of the last 3 weeks but v high compared to first 4 months of the year.
I note that we are due year end figures by end of month ie next Friday, later than in previous years and this delay has me scratching my head somewhat.

A good start today at PHC.
Looking forward to a further new geographical area of the world signing up for PHC product.


Bid alert!
I see, once again no surprise ,that trading activity on Thursday and Friday last week very active by PHC standards although not as active as Wednesday..but still active enough for people to exit. Activity today better than Friday.
Perhaps people put off by comments on need for more working capital finance not surprising given the cash burn of us1.7m in the first 4 months(facturing in the receivables payment) in the context of cash at us2.3m at end April.
I have been trying to figure out what is the main user of working capital.. At first glance you could say it is payables. At 12.21 and 12.22 trade payable were us1.3m and us1.6m way below inventories which were us2 1m and us 3.4m but the problem with that is that raw material inventories were low, there is no work in progress and the vast bulk are finished goods. Of course we are only told trade payables on one day a year and the business has moved on.
Total receivables in H1 23 were just under 90 days but 101 days  in H122 and about 55 days in H2 22. Difficult to get a steer as they move around so much.
I am perplexed by the us1.5m receivable paid in January given that total receivables at June 30 were us2.5m.
It would not have been from Wilbur Ellis and Nutrien who are far too big to mess around with a to them very small figure and presumably given that Saori sales are made mid year there would have been no receivables outstanding from Nutrien.I can only assume it is tied to Brazil sugar cane sales but even that figure seems v large.
I hope that in the IMC we can go into the working capital cycle.

All rather big picture but still good to read this in the May 8 quarterly earnings statement from Nutrien the Sairi distributor
• Brazilian growers are finalizing their soybean harvest, and favorable weather conditions resulted in safrinha corn planted area exceeding initial expectations. Soybean margins are expected to improve from the compressed levels in 2023 and support growth in planted acreage and crop input demand in the second half of 2024

So you decided to sell a bullish breakout .... and buy a downtrend in a company that's struggling to publish results amid the sudden departure of the CEO and year-on-year net income decline.
Oh well, at least there's the dividend ..... until there isn't.

I suppose it's a random walk so good luck to you.

Money moved to APH
Our mm should go back to dads veg stall, 20% spread is not mm
No surprise that the volume of shares traded yesterday was broadly in line with the total traded in April and more than that traded in February.
Let's hope that this increased volume is allowing all those who want to exit to do so.

This is just the start. Wait until they start selling in China (distribution deal in place), India and the EU; as well as N & S America. We're just getting going here.
As CR says, he wants a "PHC product on every field".

I'm sure there is plenty of mileage here.
And chart looks interesting. Upwards break after 4 months going sideways.
I have doubled up my holding. Hope that was wise!
Good for them keeping gross margin stable.
I ask myself why the delay in getting the audited figures out...not a complicated business.
I ask myself why not using Nutrien to distribute Teikko and at what stage on the soya crop cycle it is applied

TO bid coming next?
Chat Pages: 56  55  54  53  52  51  50  49  48  47  46  45  Older

Your Recent History

Delayed Upgrade Clock